Testing effectiveness (Phase 2)WithdrawnNCT02228512
What this trial is testing
Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
Who this might be right for
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman DiseasePrimary Effusion Lymphoma
National Cancer Institute (NCI)